Showing results (251-260 of 262) with videos related to
Sort By:
Pageof 27
Annals of Neurology|July 4, 2024
Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis PatientsMatthew R Brier, Suzanne E Schindler, Amber Salter, et al.Neurology. Clinical Practice|May 1, 2018
Effectiveness of alternative dose fingolimod for multiple sclerosisErin E Longbrake, Daniel Kantor, Siddharama Pawate, et al.The New England Journal of Medicine|August 7, 2020
Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, et al.Ebiomedicine|January 31, 2022
Alterations of host-gut microbiome interactions in multiple sclerosisClaudia Cantoni, Qingqi Lin, Yair Dorsett, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 13, 2024
Randomised controlled trial of intermittent calorie restriction in people with multiple sclerosisLaura Ghezzi, Valeria Tosti, Lisa Shi, et al.Neurology|September 2, 2016
The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter studyAndrew J Solomon, Dennis N Bourdette, Anne H Cross, et al.Proceedings of the National Academy of Sciences of the United States of America|April 4, 2025
A disease-specific convergence of host and Epstein-Barr virus genetics in multiple sclerosisRosella Mechelli, Renato Umeton, Gianmarco Bellucci, et al.The Lancet. Neurology|December 2, 2015
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trialRhonda R Voskuhl, HeJing Wang, T C Jackson Wu, et al.Proceedings of the National Academy of Sciences of the United States of America|January 12, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activityKoji Shinoda, Rui Li, Ayman Rezk, et al.JAMA Neurology|March 11, 2024
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple SclerosisAnne H Cross, Jeffrey M Gelfand, Simon Thebault, et al.Pageof 27